by Martina | Mar 18, 2026 | News
NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in the UK, marking another step in the company’s international growth. Through this collaboration, NADMED’s CE-marked NAD measurement technology will be integrated into...
by Martina | Feb 5, 2026 | News
A new abstract, presented at the American Stroke Association’s Conference, explores how NAD and NADP, critical molecules for cellular energy and repair, change in the early days after stroke and what that might mean for recovery. Preliminary findings (n=18) showed: •...
by Martina | Jan 4, 2026 | News
A study in Cell Reports Medicine shows significantly lower NAD+ levels in the brains of Alzheimer’s patients, especially in the parietal and occipital regions. The findings highlight a strong correlation between NAD+ depletion and mitochondrial dysfunction,...
by Martina | Nov 26, 2025 | News
A newly published study reveals that NAD⁺ can restore memory in Alzheimer’s disease models by correcting RNA splicing errors. This groundbreaking international research demonstrates how boosting this essential metabolic molecule improves memory and neuronal function...
by Martina | Sep 12, 2025 | News
NADMED has been selected to join the prestigious AMPlify program, a U.S. market entry initiative jointly organized by Mayo Clinic and Business Finland. The program combines world-class clinical expertise, valuable market knowledge, and extensive networks to support...